R&G PharmaStudies Co (SZSE:301333) FCF Margin % : 10.90% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is R&G PharmaStudies Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. R&G PharmaStudies Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥19.3 Mil. R&G PharmaStudies Co's Revenue for the three months ended in Mar. 2024 was ¥177.3 Mil. Therefore, R&G PharmaStudies Co's FCF Margin % for the quarter that ended in Mar. 2024 was 10.90%.

As of today, R&G PharmaStudies Co's current FCF Yield % is 3.95%.

The historical rank and industry rank for R&G PharmaStudies Co's FCF Margin % or its related term are showing as below:

SZSE:301333' s FCF Margin % Range Over the Past 10 Years
Min: 3.84 Med: 17.71 Max: 28.11
Current: 24.03

During the past 10 years, the highest FCF Margin % of R&G PharmaStudies Co was 28.11%. The lowest was 3.84%. And the median was 17.71%.

SZSE:301333's FCF Margin % is ranked better than
93.18% of 1041 companies
in the Biotechnology industry
Industry Median: -141.21 vs SZSE:301333: 24.03

R&G PharmaStudies Co FCF Margin % Historical Data

The historical data trend for R&G PharmaStudies Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R&G PharmaStudies Co FCF Margin % Chart

R&G PharmaStudies Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

18.21

3.84

12.54

17.20

23.94

R&G PharmaStudies Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															9.17	8.24	50.73	29.89	10.90

Competitive Comparison of R&G PharmaStudies Co's FCF Margin %

For the Biotechnology subindustry, R&G PharmaStudies Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

R&G PharmaStudies Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, R&G PharmaStudies Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where R&G PharmaStudies Co's FCF Margin % falls into.

R&G PharmaStudies Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

R&G PharmaStudies Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	172.682	/	721.373
	=	23.94 %

R&G PharmaStudies Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	19.333	/	177.331
	=	10.90 %

R&G PharmaStudies Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of R&G PharmaStudies Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

R&G PharmaStudies Co (SZSE:301333) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » R&G PharmaStudies Co Ltd (SZSE:301333) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 518, Chuangyi West Road, East District, Economic Development Zone, Tongzhou District, Beijing, CHN, 100048

Website

R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.

R&G PharmaStudies Co (SZSE:301333) Headlines

No Headlines